Picture of Elutia logo

ELUT — Elutia News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Brief: Aziyo Biologics Appoints Randal Mills As Interim President And CEO

June 21 (Reuters) - Aziyo Biologics Inc  AZYO.O :
    * AZIYO BIOLOGICS APPOINTS DR. C. RANDAL MILLS AS INTERIM PRESIDENT AND CEO
    * AZIYO BIOLOGICS INC - RONALD LLOYD WILL STEP DOWN FROM THESE POSITIONS BUT
WILL
REMAIN WITH COMPANY THROUGH END OF Q3 TO ASSIST WITH TRANSITION
    * AZIYO BIOLOGICS INC - AZIYO CO-FOUNDER KEVIN RAKIN HAS ALSO ASSUMED ROLE
OF
EXECUTIVE CHAIRMAN
    * AZIYO BIOLOGICS INC - COMPANY REAFFIRMS ITS PREVIOUSLY PROVIDED GUIDANCE
THAT
TOTAL NET SALES FOR FULL YEAR 2022 WILL RANGE BETWEEN OF $47 TO $50 MILLION

Source text for Eikon:  ID:nGNX5Htvp3 
Further company coverage:  AZYO.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Elutia

See all news